CRISPRMED24 Testimonial - Pietro De Angeli PhD
By: WeDoCRISPR - Nov. 24, 2024
Pietro De Angeli PhD is a Project Lead Scientist in Professor Bernd Wissinger’s team at the Institute for Ophthalmic Research, Tübingen University Hospital, Germany. Here, he is involved in pre-clinical gene-editing research for inherited retinal disorders. Hear what he has to say anout CRISPRMED24!
Tags
CLINICAL TRIALS
IND Enabling
Phase I
Phase II
Phase III
Gastric Cancer and Colorectal Cancer, CRC, (NCT07166263)
Sponsors:
Base Therapeutics (Shanghai) Co., Ltd.
Sponsors:
Base Therapeutics (Shanghai) Co., Ltd.
IND Enabling
Phase I
Phase II
Phase III
Relapsed or Refractory Acute Myeloid Leukemia, AML, (NCT06541444)
Sponsors:
Base Therapeutics (Shanghai) Co., Ltd.
Sponsors:
Base Therapeutics (Shanghai) Co., Ltd.
IND Enabling
Phase I
Phase II
Phase III